DKA vs HHS: Acid-Base, Osmolality and Treatment | Part 1 | 血糖急症 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state share impaired insulin action,
but differ in the relative contributions of ketogenesis, dehydration and hyperosmolality.
Diabetic ketoacidosis arises from absolute insulin deficiency.
The body behaves as if starving, lipolysis releases fatty acids,
and the liver converts them into ketoacids.
The hyperosmolar hyperglycaemic state arises when a little insulin remains.
That remnant cannot control glucose, but it suppresses lipolysis and ketogenesis,
so acidosis is absent.
Glucose instead climbs above 33 mmol/L, osmotic diuresis becomes torrential,
and the effective osmolality exceeds 320 mOsm/kg.
Ketoacidosis is defined by a pH below 7.3,
a bicarbonate below 18 mmol/L and strongly positive ketones.
It is typical of type 1 disease,
although type 2 patients under severe stress
or on SGLT2 inhibitors are not immune.

The acid-base picture is a high anion gap metabolic acidosis with respiratory compensation.
Ketoacids consume bicarbonate,
and Kussmaul breathing lowers carbon dioxide to defend the pH.
The expected carbon dioxide follows Winter's formula,
1.5 times the bicarbonate plus 8.
A value above prediction signals a tiring patient and a mixed disorder.
Two electrolytes deceive.
Measured sodium is diluted as glucose draws water from cells,
so it must be corrected upward before dehydration is judged.

Potassium is shifted out of cells by insulin deficiency and acidosis,
so the serum value is normal or high
while the total body store is depleted.

Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state share impaired insulin action,
but differ in the relative contributions of ketogenesis, dehydration and hyperosmolality.


Treatment therefore follows a fixed sequence: fluid, potassium, then insulin.
Isotonic saline restores perfusion, one litre in the first hour.
Potassium is read before insulin is started.
Below 3.3 mmol/L, insulin is withheld until potassium is replaced.
Between 3.3 and 5.2 mmol/L,
20 to 30 mmol is added to each litre.
Above 5.2 mmol/L, none is given yet.
A fixed-rate intravenous infusion of 0.1 units per kilogram per hour
then follows.
Oral hypoglycaemic agents have no place.
Once glucose falls below about 14 mmol/L,
10 per cent dextrose is added,
and the insulin continues until ketones are below 0.6 mmol/L,
pH exceeds 7.3 and the anion gap has closed.
Basal insulin is given before the infusion stops.

Bicarbonate is not routine.
It is considered only when the pH is below 6.9,
because earlier use deepens hypokalaemia,
shifts the oxygen dissociation curve leftward and may paradoxically acidify the brain.
Cerebral oedema is the feared complication in children and young adults.
Headache,
a falling heart rate with rising blood pressure
and a declining conscious level demand immediate treatment.
Glucose should fall by roughly 3 mmol/L per hour, never faster.

Prevention is the sick-day rule.
Basal insulin is never omitted,
glucose is checked every two to four hours,
and ketones are measured whenever glucose exceeds 15 mmol/L or vomiting begins.
Ketones above 1.5 mmol/L
or an inability to keep fluids down mean hospital,
not waiting.
Hypoglycaemia sits at the other end of the same axis.
A conscious patient takes fifteen grams of glucose
and rechecks after fifteen minutes;
an unconscious patient receives intravenous dextrose or intramuscular glucagon,
the counter-regulatory hormone from alpha cells.

Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state share impaired insulin action,
but differ in the relative contributions of ketogenesis, dehydration and hyperosmolality.

Medical Notes · 醫學學習提示

  1. DKA 與 HHS 都涉及胰島素作用不足;本片為成人重點
  2. 兩者差在酮體、脫水與高滲透壓,亦可混合出現
  3. DKA 可由絕對或嚴重相對胰島素不足引起
  4. 脂肪分解釋出脂肪酸,提供肝臟生酮原料
  5. 脂肪酸在肝臟轉成酮體;圖為代謝相關正常組織
  6. HHS 常仍有足以抑制大量生酮的胰島素
  7. 剩餘作用可抑制生酮,卻不足以控制高血糖
  8. 純 HHS 無明顯酸中毒;須辨識混合型 DKA/HHS
  9. 現行 HHS 血糖門檻為 ≥33.3 mmol/L
  10. 現行門檻:有效滲透壓 >300,或總滲透壓 >320
  11. DKA 酸中毒:pH <7.3 或 HCO3 <18,非兩者必備
  12. 另須糖尿病/高血糖及血酮 ≥3.0 mmol/L 等條件
  13. DKA 常見於第一型糖尿病,但不限於此
  14. 第二型在感染、急病等壓力下也可發生
  15. SGLT2 相關 DKA 可在血糖不明顯升高時出現
  16. 常見高陰離子間隙酸中毒,也可合併其他失衡
  17. 酮酸累積消耗碳酸氫鹽,降低緩衝能力
  18. 深快呼吸可代償酸中毒,但不能消除原病因
  19. Winter 公式評估代謝性酸中毒的呼吸代償
  20. 預期 PaCO2=1.5 × HCO3+8,容許約 ±2 mmHg
  21. 實測高於預期提示合併呼吸性酸中毒,須評估原因
  22. 血鈉與血鉀都須連同血糖、腎功能及趨勢判讀
  23. 高血糖將細胞內水分拉到細胞外,稀釋血鈉
  24. 校正鈉提供參考;脫水仍須合併循環與滲透壓評估
  25. 胰島素不足及酸鹼變化可使鉀移出細胞
  26. 血鉀正常或偏高,不代表全身鉀儲量正常
  27. 滲透性利尿與嘔吐可造成全身鉀缺乏
  28. 共同核心是胰島素不足與嚴重體液失衡
  29. DKA 偏重酮酸;HHS 偏重高滲與脫水,可重疊
  30. 補液、血鉀與胰島素須配合監測,不是僵化順序
  31. 等張鹽水或平衡晶體液;速度須依心腎與循環調整
  32. 啟動胰島素前先確認血鉀與補鉀需求
  33. 更新:血鉀 <3.5 時先補鉀,升至 >3.5 再給胰島素
  34. 歌詞 3.3–5.2 是舊門檻;現行補鉀起點為 <5.0
  35. 補鉀量依血鉀、腎功能、尿量與院內流程調整
  36. 血鉀偏高先不補,但治療後可快速下降,須複測
  37. 0.1 U/kg/h 常用於 DKA 或混合型;非所有 HHS
  38. 無明顯酮酸中毒的 HHS 常用較低胰島素速率
  39. 急性危象治療靠補液與胰島素,口服藥不能替代
  40. 血糖約降至 13.9 mmol/L 以下,須考慮加葡萄糖
  41. 可用 5–10% 葡萄糖,使胰島素得以持續清酮
  42. DKA 緩解須血酮 <0.6 mmol/L 並符合酸鹼條件
  43. pH ≥7.3 或 HCO3 ≥18;不以陰離子間隙作緩解標準
  44. 皮下胰島素與靜脈輸注須適當重疊,避免反彈
  45. 碳酸氫鹽不常規使用,須由急症團隊評估
  46. 更新:現行成人共識於嚴重酸中毒 pH <7.0 考慮
  47. 補鹼可能加重低血鉀,須密切監測
  48. 過度補鹼可能影響氧釋放與中樞酸鹼狀態
  49. 腦損傷須警覺;兒童另依兒科 DKA 流程
  50. 治療中出現頭痛或神經變化須立即重新評估
  51. 心率下降、血壓上升可提示顱內壓問題
  52. 意識惡化須立即處理;圖為正常腦構造示意
  53. 下降速率依 DKA/HHS 與滲透壓,不一律限 3
  54. 生病日計畫要事先與糖尿病團隊訂好
  55. 第一型勿自行停基礎胰島素;劑量依計畫調整
  56. 生病時增加血糖監測頻率,依個人計畫執行
  57. 嘔吐或疑 DKA 就驗酮;SGLT2 使用者勿只看血糖
  58. 血酮升高須依個人計畫及症狀立即聯絡醫療團隊
  59. 喝不下、持續嘔吐、呼吸異常或嗜睡須緊急就醫
  60. 疑危象不等待下次例行回診
  61. 低血糖也須即時辨識與處理
  62. 清醒且能安全吞嚥者可先補 15 克快速糖
  63. 約 15 分鐘後複測,未改善依計畫再處理
  64. 昏迷勿餵食:緊急求援,使用升糖素或靜脈葡萄糖
  65. 升糖素由胰島 α 細胞分泌,促進肝臟釋放葡萄糖
  66. 回顧:DKA 與 HHS 都是需即時治療的代謝危象
  67. 診斷及處置須同看血酮、酸鹼、電解質與滲透壓

References